A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in ...

Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic cancer. This device, called Optune | Cancer ...

A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

For the first time in 30 years, there is a new FDA-approved treatment for locally advanced pancreatic cancer.

A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an ...

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, announced today that the Company will ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

LOUISVILLE, Ky. — Norton Healthcare's Audubon Hospital has a new treatment for pancreatic cancer that can extend survival rates and improve the overall quality of life for patients. In a news release ...

Pancreatic cancer treatment relies on surgery, chemotherapy, and radiation, with surgery for non-metastatic, technically resectable tumors. Advances in chemotherapy, neoadjuvant approaches, and ...